Baudin E - Search Results

1

Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study.

Berruti A, Libè R, Laganà M, Ettaieb H, Sukkari MA, Bertherat J, Feelders RA, Grisanti S, Cartry J, Mazziotti G, Sigala S, Baudin E, Haak H, Habra MA, Terzolo M. Berruti A, et al. Among authors: baudin e. Eur J Endocrinol. 2019 May 1;180(5):311-320. doi: 10.1530/EJE-19-0026. Eur J Endocrinol. 2019. PMID: 30970324 Free article.

2

Adrenocortical carcinoma.

Gicquel C, Baudin E, Lebouc Y, Schlumberger M. Gicquel C, et al. Among authors: baudin e. Ann Oncol. 1997 May;8(5):423-7. doi: 10.1023/a:1008257530919. Ann Oncol. 1997. PMID: 9233519 Free article. Review. No abstract available.

3

Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma.

Schlumberger M, Baudin E. Schlumberger M, et al. Among authors: baudin e. Eur J Endocrinol. 1998 Mar;138(3):249-52. doi: 10.1530/eje.0.1380249. Eur J Endocrinol. 1998. PMID: 9539294 No abstract available.

4

Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma.

Bonacci R, Gigliotti A, Baudin E, Wion-Barbot N, Emy P, Bonnay M, Cailleux AF, Nakib I, Schlumberger M; Réseau Comète. Bonacci R, et al. Among authors: baudin e. Br J Cancer. 1998 Aug;78(4):546-9. doi: 10.1038/bjc.1998.530. Br J Cancer. 1998. PMID: 9716042 Free PMC article. Clinical Trial.

5

Gastroenteropancreatic neuroendocrine tumor metastases to the thyroid gland: differential diagnosis with medullary thyroid carcinoma.

Leboulleux S, Baudin E, Young J, Caillou B, Lazar V, Pellegriti G, Ducreux M, Schaison G, Schlumberger M. Leboulleux S, et al. Among authors: baudin e. Eur J Endocrinol. 1999 Mar;140(3):187-91. doi: 10.1530/eje.0.1400187. Eur J Endocrinol. 1999. PMID: 10216512

6

Establishment and characterization of a human adrenocortical carcinoma xenograft model.

Logié A, Boudou P, Boccon-Gibod L, Baudin E, Vassal G, Schlumberger M, Le Bouc Y, Gicquel C. Logié A, et al. Among authors: baudin e. Endocrinology. 2000 Sep;141(9):3165-71. doi: 10.1210/endo.141.9.7668. Endocrinology. 2000. PMID: 10965887

7

Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors.

Boulle N, Baudin E, Gicquel C, Logié A, Bertherat J, Penfornis A, Bertagna X, Luton JP, Schlumberger M, Le Bouc Y. Boulle N, et al. Among authors: baudin e. Eur J Endocrinol. 2001 Jan;144(1):29-36. doi: 10.1530/eje.0.1440029. Eur J Endocrinol. 2001. PMID: 11174834

8

Use of a topoisomerase I inhibitor (irinotecan, CPT-11) in metastatic adrenocortical carcinoma.

Baudin E, Docao C, Gicquel C, Vassal G, Bachelot A, Penfornis A, Schlumberger M. Baudin E, et al. Ann Oncol. 2002 Nov;13(11):1806-9. doi: 10.1093/annonc/mdf291. Ann Oncol. 2002. PMID: 12419755 Free article. Clinical Trial.

9

Medullary thyroid carcinoma.

Leboulleux S, Baudin E, Travagli JP, Schlumberger M. Leboulleux S, et al. Among authors: baudin e. Clin Endocrinol (Oxf). 2004 Sep;61(3):299-310. doi: 10.1111/j.1365-2265.2004.02037.x. Clin Endocrinol (Oxf). 2004. PMID: 15355445 Review.

10

Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy.

de Fraipont F, El Atifi M, Cherradi N, Le Moigne G, Defaye G, Houlgatte R, Bertherat J, Bertagna X, Plouin PF, Baudin E, Berger F, Gicquel C, Chabre O, Feige JJ. de Fraipont F, et al. Among authors: baudin e. J Clin Endocrinol Metab. 2005 Mar;90(3):1819-29. doi: 10.1210/jc.2004-1075. Epub 2004 Dec 21. J Clin Endocrinol Metab. 2005. PMID: 15613424 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

466 results

Search Page

Filters